| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Computational Biology | 28 | 2018 | 3564 | 1.820 |
Why?
|
| Software | 28 | 2019 | 4466 | 1.490 |
Why?
|
| Sequence Analysis, Protein | 8 | 2015 | 261 | 1.110 |
Why?
|
| Neoplasms | 32 | 2018 | 22350 | 0.980 |
Why?
|
| Genomics | 23 | 2017 | 5923 | 0.930 |
Why?
|
| Neoplasm Proteins | 8 | 2017 | 3601 | 0.830 |
Why?
|
| Gene Expression Profiling | 37 | 2017 | 9525 | 0.820 |
Why?
|
| Proteins | 19 | 2019 | 6002 | 0.810 |
Why?
|
| MicroRNAs | 27 | 2016 | 3792 | 0.800 |
Why?
|
| Systems Biology | 5 | 2015 | 481 | 0.790 |
Why?
|
| Databases, Genetic | 13 | 2018 | 1756 | 0.780 |
Why?
|
| Models, Chemical | 2 | 2015 | 607 | 0.780 |
Why?
|
| Programming Languages | 5 | 2015 | 133 | 0.730 |
Why?
|
| DNA, Mitochondrial | 2 | 2017 | 872 | 0.730 |
Why?
|
| Liposarcoma | 6 | 2013 | 288 | 0.710 |
Why?
|
| Signal Transduction | 33 | 2018 | 23619 | 0.680 |
Why?
|
| Models, Biological | 14 | 2015 | 9461 | 0.640 |
Why?
|
| Protein Interaction Mapping | 8 | 2015 | 621 | 0.640 |
Why?
|
| Gene Regulatory Networks | 11 | 2015 | 1751 | 0.630 |
Why?
|
| DNA Copy Number Variations | 12 | 2016 | 2045 | 0.620 |
Why?
|
| Mutation | 42 | 2018 | 30213 | 0.550 |
Why?
|
| Databases, Protein | 9 | 2018 | 390 | 0.540 |
Why?
|
| Genes, Neoplasm | 5 | 2018 | 369 | 0.530 |
Why?
|
| Models, Genetic | 11 | 2012 | 3450 | 0.530 |
Why?
|
| Cell Respiration | 1 | 2017 | 201 | 0.520 |
Why?
|
| DNA Mutational Analysis | 12 | 2017 | 4114 | 0.510 |
Why?
|
| Evolution, Molecular | 11 | 2018 | 1892 | 0.510 |
Why?
|
| Entropy | 4 | 2016 | 210 | 0.500 |
Why?
|
| Gene Expression Regulation, Neoplastic | 21 | 2018 | 8621 | 0.490 |
Why?
|
| Sequence Alignment | 10 | 2019 | 2177 | 0.480 |
Why?
|
| Indicators and Reagents | 1 | 2014 | 456 | 0.440 |
Why?
|
| Glioblastoma | 9 | 2015 | 3458 | 0.440 |
Why?
|
| Cytological Techniques | 1 | 2015 | 217 | 0.440 |
Why?
|
| RNA, Messenger | 22 | 2017 | 12791 | 0.430 |
Why?
|
| Protein Array Analysis | 1 | 2014 | 399 | 0.420 |
Why?
|
| Carcinoma, Renal Cell | 10 | 2017 | 3186 | 0.420 |
Why?
|
| Proteomics | 8 | 2016 | 3914 | 0.410 |
Why?
|
| Models, Molecular | 13 | 2018 | 5386 | 0.410 |
Why?
|
| Protein Conformation | 10 | 2018 | 3947 | 0.410 |
Why?
|
| Gene Dosage | 9 | 2017 | 1211 | 0.390 |
Why?
|
| Actigraphy | 1 | 2016 | 526 | 0.390 |
Why?
|
| Cell Line, Tumor | 30 | 2018 | 17088 | 0.390 |
Why?
|
| Internet | 17 | 2017 | 3113 | 0.390 |
Why?
|
| Databases, Factual | 12 | 2017 | 8066 | 0.380 |
Why?
|
| User-Computer Interface | 9 | 2017 | 1409 | 0.380 |
Why?
|
| Genome, Human | 13 | 2018 | 4443 | 0.370 |
Why?
|
| RNA, Small Interfering | 8 | 2012 | 3425 | 0.370 |
Why?
|
| Computer Graphics | 5 | 2014 | 345 | 0.370 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2013 | 385 | 0.370 |
Why?
|
| Algorithms | 18 | 2018 | 14072 | 0.370 |
Why?
|
| Cyclin-Dependent Kinase 4 | 2 | 2014 | 562 | 0.350 |
Why?
|
| Genetic Variation | 7 | 2017 | 6612 | 0.340 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2010 | 109 | 0.340 |
Why?
|
| Drug Resistance | 1 | 2015 | 1592 | 0.320 |
Why?
|
| Gene Expression Regulation | 9 | 2013 | 11920 | 0.320 |
Why?
|
| Metabolomics | 2 | 2018 | 1675 | 0.320 |
Why?
|
| High-Throughput Screening Assays | 1 | 2014 | 938 | 0.320 |
Why?
|
| Oncogenes | 2 | 2018 | 1231 | 0.310 |
Why?
|
| Escherichia coli | 4 | 2018 | 4211 | 0.310 |
Why?
|
| Information Storage and Retrieval | 7 | 2013 | 832 | 0.310 |
Why?
|
| Protein Structure, Tertiary | 8 | 2017 | 3757 | 0.300 |
Why?
|
| Kidney Neoplasms | 8 | 2017 | 4282 | 0.300 |
Why?
|
| Drug Combinations | 2 | 2015 | 2085 | 0.300 |
Why?
|
| Mutation, Missense | 3 | 2014 | 2590 | 0.300 |
Why?
|
| Systems Integration | 6 | 2010 | 425 | 0.290 |
Why?
|
| Gene Silencing | 5 | 2013 | 1504 | 0.290 |
Why?
|
| Combinatorial Chemistry Techniques | 1 | 2007 | 136 | 0.270 |
Why?
|
| Gene Expression | 5 | 2017 | 7585 | 0.260 |
Why?
|
| Models, Statistical | 5 | 2015 | 5091 | 0.260 |
Why?
|
| Proteome | 6 | 2017 | 1894 | 0.250 |
Why?
|
| Genome | 7 | 2015 | 1752 | 0.250 |
Why?
|
| Ovarian Neoplasms | 6 | 2013 | 4904 | 0.250 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2018 | 502 | 0.250 |
Why?
|
| Molecular Sequence Data | 15 | 2017 | 17608 | 0.250 |
Why?
|
| Humans | 134 | 2018 | 766766 | 0.250 |
Why?
|
| Drug Interactions | 1 | 2010 | 1419 | 0.250 |
Why?
|
| Drug Discovery | 1 | 2013 | 1065 | 0.240 |
Why?
|
| Escherichia coli Proteins | 3 | 2018 | 1055 | 0.240 |
Why?
|
| Tumor Suppressor Protein p53 | 8 | 2018 | 2948 | 0.240 |
Why?
|
| Antibodies | 1 | 2013 | 2421 | 0.240 |
Why?
|
| Arousal | 3 | 2018 | 1174 | 0.240 |
Why?
|
| Models, Theoretical | 3 | 2015 | 3561 | 0.230 |
Why?
|
| Cluster Analysis | 6 | 2016 | 2717 | 0.230 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2006 | 304 | 0.230 |
Why?
|
| Metabolism | 1 | 2006 | 193 | 0.230 |
Why?
|
| DNA Polymerase II | 2 | 2015 | 103 | 0.230 |
Why?
|
| Mitochondria | 2 | 2017 | 3677 | 0.230 |
Why?
|
| Protein Biosynthesis | 3 | 2010 | 2093 | 0.220 |
Why?
|
| Sequence Analysis, RNA | 3 | 2018 | 2039 | 0.220 |
Why?
|
| Brain Neoplasms | 4 | 2015 | 9101 | 0.220 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2015 | 2839 | 0.220 |
Why?
|
| GTP Phosphohydrolases | 1 | 2007 | 525 | 0.210 |
Why?
|
| Proto-Oncogene Proteins c-akt | 6 | 2016 | 2456 | 0.210 |
Why?
|
| Conserved Sequence | 5 | 2017 | 1159 | 0.210 |
Why?
|
| Sleep | 2 | 2016 | 4815 | 0.210 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2014 | 1117 | 0.210 |
Why?
|
| Genes, p53 | 3 | 2015 | 711 | 0.200 |
Why?
|
| Anti-Infective Agents | 1 | 2010 | 987 | 0.200 |
Why?
|
| Binding Sites | 9 | 2018 | 6012 | 0.200 |
Why?
|
| Database Management Systems | 4 | 2012 | 263 | 0.200 |
Why?
|
| raf Kinases | 2 | 2015 | 117 | 0.200 |
Why?
|
| Melanoma | 5 | 2015 | 5700 | 0.190 |
Why?
|
| Down-Regulation | 7 | 2015 | 2931 | 0.190 |
Why?
|
| Computer Simulation | 7 | 2018 | 6259 | 0.190 |
Why?
|
| Protein Binding | 11 | 2018 | 9320 | 0.180 |
Why?
|
| Prostatic Neoplasms | 10 | 2018 | 11094 | 0.180 |
Why?
|
| Transforming Growth Factor beta | 3 | 2018 | 1996 | 0.180 |
Why?
|
| Protein Structure, Secondary | 5 | 2016 | 1211 | 0.180 |
Why?
|
| Tumor Suppressor Proteins | 6 | 2014 | 2801 | 0.180 |
Why?
|
| Amino Acid Sequence | 8 | 2017 | 13411 | 0.180 |
Why?
|
| Antineoplastic Agents | 5 | 2016 | 13643 | 0.180 |
Why?
|
| Genome-Wide Association Study | 7 | 2018 | 12806 | 0.180 |
Why?
|
| Gene Amplification | 4 | 2014 | 1088 | 0.170 |
Why?
|
| Ubiquitin Thiolesterase | 3 | 2013 | 456 | 0.170 |
Why?
|
| Survival Analysis | 3 | 2013 | 10100 | 0.170 |
Why?
|
| ras Proteins | 5 | 2018 | 1055 | 0.170 |
Why?
|
| Metabolic Networks and Pathways | 3 | 2015 | 800 | 0.170 |
Why?
|
| Polymorphism, Single Nucleotide | 10 | 2018 | 16044 | 0.170 |
Why?
|
| Base Sequence | 12 | 2013 | 12415 | 0.170 |
Why?
|
| Phosphatidylinositol 3-Kinases | 7 | 2018 | 2881 | 0.160 |
Why?
|
| DNA, Neoplasm | 2 | 2015 | 1741 | 0.160 |
Why?
|
| Genes, myc | 2 | 2011 | 391 | 0.160 |
Why?
|
| Periplasmic Binding Proteins | 1 | 2018 | 34 | 0.160 |
Why?
|
| DNA Methylation | 8 | 2017 | 4427 | 0.160 |
Why?
|
| TOR Serine-Threonine Kinases | 5 | 2016 | 2060 | 0.160 |
Why?
|
| Retinoblastoma Protein | 2 | 2014 | 670 | 0.150 |
Why?
|
| Sequence Analysis | 1 | 2019 | 240 | 0.150 |
Why?
|
| Microbial Consortia | 1 | 2018 | 35 | 0.150 |
Why?
|
| Breast Neoplasms | 8 | 2015 | 21162 | 0.150 |
Why?
|
| Cystadenocarcinoma, Serous | 2 | 2013 | 480 | 0.150 |
Why?
|
| Genetic Association Studies | 4 | 2016 | 2746 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2018 | 18075 | 0.150 |
Why?
|
| Epistasis, Genetic | 2 | 2017 | 353 | 0.140 |
Why?
|
| Rest | 3 | 2018 | 940 | 0.140 |
Why?
|
| DNA Repair | 3 | 2015 | 2050 | 0.140 |
Why?
|
| GTP-Binding Proteins | 2 | 2012 | 946 | 0.140 |
Why?
|
| Epigenomics | 2 | 2013 | 959 | 0.130 |
Why?
|
| Cell Cycle Proteins | 2 | 2011 | 3439 | 0.130 |
Why?
|
| Integrin alpha Chains | 1 | 2016 | 93 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 3 | 3 | 2013 | 322 | 0.130 |
Why?
|
| Documentation | 3 | 2015 | 914 | 0.130 |
Why?
|
| Multigene Family | 3 | 2015 | 1081 | 0.130 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2016 | 163 | 0.130 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 11872 | 0.130 |
Why?
|
| Casein Kinase II | 1 | 2016 | 121 | 0.130 |
Why?
|
| Nuclear Proteins | 5 | 2017 | 5795 | 0.130 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2017 | 246 | 0.130 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2011 | 996 | 0.120 |
Why?
|
| Animals | 39 | 2018 | 168930 | 0.120 |
Why?
|
| Phenotype | 8 | 2016 | 16724 | 0.120 |
Why?
|
| Genes, Mitochondrial | 1 | 2015 | 59 | 0.120 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2017 | 330 | 0.120 |
Why?
|
| Intestines | 2 | 2014 | 1904 | 0.120 |
Why?
|
| Glioma | 3 | 2015 | 3498 | 0.120 |
Why?
|
| Exonucleases | 1 | 2014 | 42 | 0.120 |
Why?
|
| Mice | 25 | 2018 | 81889 | 0.120 |
Why?
|
| Fibrosarcoma | 1 | 2016 | 313 | 0.120 |
Why?
|
| Molecular Sequence Annotation | 2 | 2014 | 526 | 0.120 |
Why?
|
| Amino Acids | 3 | 2014 | 1711 | 0.120 |
Why?
|
| Electron Transport | 1 | 2015 | 211 | 0.120 |
Why?
|
| RNA Processing, Post-Transcriptional | 3 | 2007 | 393 | 0.110 |
Why?
|
| Calcium Channels, L-Type | 1 | 2015 | 243 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2016 | 1899 | 0.110 |
Why?
|
| Regulatory Elements, Transcriptional | 1 | 2014 | 183 | 0.110 |
Why?
|
| Ecology | 1 | 2013 | 105 | 0.110 |
Why?
|
| Polymorphism, Genetic | 3 | 2014 | 4249 | 0.110 |
Why?
|
| Transcription Factors | 6 | 2017 | 12150 | 0.110 |
Why?
|
| Alternative Splicing | 1 | 2018 | 1103 | 0.110 |
Why?
|
| Epigenesis, Genetic | 4 | 2013 | 3824 | 0.100 |
Why?
|
| Pathology, Molecular | 1 | 2016 | 329 | 0.100 |
Why?
|
| Principal Component Analysis | 1 | 2016 | 949 | 0.100 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2013 | 2902 | 0.100 |
Why?
|
| RNA, Untranslated | 1 | 2016 | 455 | 0.100 |
Why?
|
| Nucleic Acid Conformation | 1 | 2016 | 899 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2013 | 386 | 0.100 |
Why?
|
| Neuronal Plasticity | 2 | 2012 | 1446 | 0.100 |
Why?
|
| Bile Acids and Salts | 1 | 2014 | 398 | 0.100 |
Why?
|
| Gene Deletion | 4 | 2014 | 2669 | 0.100 |
Why?
|
| Immunity, Cellular | 1 | 2018 | 1560 | 0.100 |
Why?
|
| Quality Control | 1 | 2014 | 834 | 0.100 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2010 | 1609 | 0.090 |
Why?
|
| Cholangiocarcinoma | 1 | 2017 | 562 | 0.090 |
Why?
|
| Bile Duct Neoplasms | 1 | 2017 | 614 | 0.090 |
Why?
|
| Carcinoma, Lobular | 1 | 2015 | 480 | 0.090 |
Why?
|
| RNA-Binding Proteins | 4 | 2016 | 1884 | 0.090 |
Why?
|
| RNA-Binding Protein FUS | 1 | 2011 | 77 | 0.090 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2013 | 1168 | 0.090 |
Why?
|
| Rhodopsin | 1 | 2011 | 202 | 0.090 |
Why?
|
| Trypsin | 1 | 2011 | 490 | 0.090 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2013 | 718 | 0.090 |
Why?
|
| TATA-Binding Protein Associated Factors | 1 | 2011 | 103 | 0.090 |
Why?
|
| Promoter Regions, Genetic | 5 | 2017 | 5789 | 0.090 |
Why?
|
| Probability | 2 | 2013 | 2476 | 0.090 |
Why?
|
| Nervous System Neoplasms | 1 | 2011 | 91 | 0.090 |
Why?
|
| Genome, Bacterial | 2 | 2014 | 796 | 0.090 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2016 | 6512 | 0.090 |
Why?
|
| Neurofibromin 1 | 1 | 2012 | 190 | 0.090 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2017 | 950 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2014 | 562 | 0.090 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2013 | 262 | 0.090 |
Why?
|
| Protein Folding | 1 | 2014 | 868 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 4 | 2015 | 4780 | 0.090 |
Why?
|
| Urinary Bladder Neoplasms | 2 | 2013 | 2184 | 0.090 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 2011 | 238 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2015 | 3796 | 0.090 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2015 | 5329 | 0.090 |
Why?
|
| Histiocytoma, Malignant Fibrous | 1 | 2010 | 54 | 0.090 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2012 | 367 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2011 | 3609 | 0.080 |
Why?
|
| Lymphoma, Follicular | 1 | 2014 | 460 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2011 | 1057 | 0.080 |
Why?
|
| DNA Replication | 2 | 2014 | 1426 | 0.080 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2015 | 1097 | 0.080 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2012 | 195 | 0.080 |
Why?
|
| GTPase-Activating Proteins | 2 | 2010 | 465 | 0.080 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2011 | 327 | 0.080 |
Why?
|
| Female | 35 | 2018 | 396520 | 0.080 |
Why?
|
| Receptor-Like Protein Tyrosine Phosphatases, Class 2 | 1 | 2009 | 21 | 0.080 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 2007 | 1057 | 0.080 |
Why?
|
| Catalytic Domain | 1 | 2011 | 699 | 0.080 |
Why?
|
| Drug Synergism | 1 | 2013 | 1756 | 0.080 |
Why?
|
| Isoenzymes | 1 | 2014 | 1688 | 0.080 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2013 | 306 | 0.080 |
Why?
|
| RNA Interference | 2 | 2010 | 2827 | 0.080 |
Why?
|
| Skin Neoplasms | 5 | 2009 | 5861 | 0.080 |
Why?
|
| PDZ Domains | 1 | 2008 | 23 | 0.080 |
Why?
|
| Superoxide Dismutase | 1 | 2011 | 595 | 0.080 |
Why?
|
| Polyomavirus | 1 | 2009 | 236 | 0.080 |
Why?
|
| Lysine | 1 | 2013 | 997 | 0.080 |
Why?
|
| RNA Stability | 1 | 2010 | 319 | 0.080 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2013 | 698 | 0.080 |
Why?
|
| Immunohistochemistry | 4 | 2016 | 11061 | 0.080 |
Why?
|
| Proto-Oncogene Proteins B-raf | 4 | 2016 | 2056 | 0.080 |
Why?
|
| Fluorine Radioisotopes | 1 | 2011 | 405 | 0.080 |
Why?
|
| Monte Carlo Method | 1 | 2013 | 1250 | 0.080 |
Why?
|
| Biomedical Research | 3 | 2008 | 3459 | 0.080 |
Why?
|
| Artificial Intelligence | 2 | 2015 | 2662 | 0.070 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2014 | 5690 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 3666 | 0.070 |
Why?
|
| Cell Line | 9 | 2015 | 15563 | 0.070 |
Why?
|
| Disease Susceptibility | 1 | 2014 | 1791 | 0.070 |
Why?
|
| Cell Proliferation | 7 | 2014 | 10445 | 0.070 |
Why?
|
| Insulinoma | 1 | 2008 | 121 | 0.070 |
Why?
|
| Polyomavirus Infections | 1 | 2009 | 193 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2014 | 2746 | 0.070 |
Why?
|
| Male | 35 | 2018 | 364142 | 0.070 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2008 | 258 | 0.070 |
Why?
|
| Genetics, Medical | 1 | 2010 | 334 | 0.070 |
Why?
|
| Poisson Distribution | 1 | 2008 | 507 | 0.070 |
Why?
|
| Glycolysis | 1 | 2011 | 838 | 0.070 |
Why?
|
| Endoribonucleases | 1 | 2008 | 230 | 0.070 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2009 | 501 | 0.070 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2014 | 1374 | 0.070 |
Why?
|
| Tumor Virus Infections | 1 | 2009 | 438 | 0.070 |
Why?
|
| Disease-Free Survival | 5 | 2015 | 6850 | 0.070 |
Why?
|
| Polyadenylation | 2 | 2004 | 114 | 0.070 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2014 | 1245 | 0.070 |
Why?
|
| Drug Design | 1 | 2011 | 1042 | 0.070 |
Why?
|
| Gene Rearrangement | 1 | 2011 | 1142 | 0.070 |
Why?
|
| Feedback, Physiological | 1 | 2009 | 481 | 0.070 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 2 | 2018 | 166 | 0.070 |
Why?
|
| Software Design | 1 | 2006 | 173 | 0.070 |
Why?
|
| Pleural Neoplasms | 1 | 2011 | 584 | 0.070 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2011 | 844 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2009 | 635 | 0.060 |
Why?
|
| Structural Homology, Protein | 2 | 2018 | 86 | 0.060 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2008 | 385 | 0.060 |
Why?
|
| Adenocarcinoma | 3 | 2013 | 6359 | 0.060 |
Why?
|
| Chromosome Aberrations | 2 | 2011 | 1776 | 0.060 |
Why?
|
| Prognosis | 7 | 2016 | 29948 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2015 | 2815 | 0.060 |
Why?
|
| Middle Aged | 19 | 2018 | 223257 | 0.060 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2011 | 2028 | 0.060 |
Why?
|
| Drosophila melanogaster | 2 | 2005 | 1725 | 0.060 |
Why?
|
| Hematopoietic System | 1 | 2005 | 110 | 0.060 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2009 | 329 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2015 | 3681 | 0.060 |
Why?
|
| Sirolimus | 1 | 2012 | 1540 | 0.060 |
Why?
|
| Neoplasm Metastasis | 5 | 2014 | 4891 | 0.060 |
Why?
|
| Disease | 1 | 2010 | 675 | 0.060 |
Why?
|
| Mesothelioma | 1 | 2011 | 774 | 0.060 |
Why?
|
| Aged | 18 | 2018 | 171343 | 0.060 |
Why?
|
| RNA | 3 | 2019 | 2715 | 0.060 |
Why?
|
| Androgens | 1 | 2012 | 1280 | 0.060 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 1749 | 0.060 |
Why?
|
| Cationic Amino Acid Transporter 1 | 1 | 2004 | 5 | 0.060 |
Why?
|
| Isotope Labeling | 2 | 2018 | 390 | 0.060 |
Why?
|
| Data Interpretation, Statistical | 1 | 2014 | 2693 | 0.060 |
Why?
|
| 3' Untranslated Regions | 4 | 2012 | 515 | 0.060 |
Why?
|
| Transfection | 2 | 2010 | 5754 | 0.060 |
Why?
|
| Homeodomain Proteins | 2 | 2012 | 2430 | 0.060 |
Why?
|
| Quantitative Trait Loci | 3 | 2018 | 2136 | 0.060 |
Why?
|
| Circadian Rhythm | 1 | 2016 | 2593 | 0.060 |
Why?
|
| Gene Library | 1 | 2007 | 1065 | 0.060 |
Why?
|
| Herpesviridae | 1 | 2005 | 104 | 0.060 |
Why?
|
| Prostate | 2 | 2011 | 1757 | 0.060 |
Why?
|
| Self Report | 1 | 2016 | 3771 | 0.060 |
Why?
|
| Radiopharmaceuticals | 2 | 2011 | 2704 | 0.060 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 1243 | 0.060 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2018 | 3114 | 0.060 |
Why?
|
| Genetic Techniques | 1 | 2007 | 428 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 3 | 2012 | 4400 | 0.060 |
Why?
|
| Precancerous Conditions | 1 | 2011 | 980 | 0.060 |
Why?
|
| Cell Division | 1 | 2011 | 4474 | 0.060 |
Why?
|
| Synapses | 2 | 2012 | 1759 | 0.050 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2007 | 633 | 0.050 |
Why?
|
| Neoplasms, Experimental | 3 | 2014 | 1227 | 0.050 |
Why?
|
| International Cooperation | 1 | 2010 | 1434 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 2004 | 205 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 3041 | 0.050 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 3944 | 0.050 |
Why?
|
| Electroencephalography | 3 | 2018 | 6282 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2016 | 4924 | 0.050 |
Why?
|
| Reproducibility of Results | 6 | 2013 | 20144 | 0.050 |
Why?
|
| Nevus, Epithelioid and Spindle Cell | 1 | 2004 | 67 | 0.050 |
Why?
|
| Lymphoma, B-Cell | 1 | 2009 | 945 | 0.050 |
Why?
|
| Colorectal Neoplasms | 2 | 2013 | 6962 | 0.050 |
Why?
|
| Adult | 17 | 2018 | 223307 | 0.050 |
Why?
|
| Testis | 1 | 2006 | 786 | 0.050 |
Why?
|
| Recurrence | 2 | 2014 | 8507 | 0.050 |
Why?
|
| Angiofibroma | 1 | 2003 | 55 | 0.050 |
Why?
|
| Immunotherapy | 2 | 2016 | 4747 | 0.050 |
Why?
|
| Genes, Fungal | 1 | 2004 | 441 | 0.050 |
Why?
|
| Crystallography, X-Ray | 2 | 2018 | 1947 | 0.050 |
Why?
|
| Thyroid Neoplasms | 1 | 2016 | 2355 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2011 | 2870 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2015 | 4047 | 0.050 |
Why?
|
| Memory | 1 | 2012 | 2192 | 0.050 |
Why?
|
| Membrane Proteins | 4 | 2014 | 7868 | 0.050 |
Why?
|
| Neoplasm Staging | 5 | 2016 | 11218 | 0.050 |
Why?
|
| Apoptosis | 7 | 2011 | 9513 | 0.050 |
Why?
|
| Drug Delivery Systems | 1 | 2013 | 2210 | 0.050 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2004 | 606 | 0.050 |
Why?
|
| Codon, Nonsense | 2 | 2014 | 287 | 0.050 |
Why?
|
| Information Dissemination | 1 | 2010 | 1142 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2011 | 4570 | 0.050 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2008 | 882 | 0.050 |
Why?
|
| Chlamydia trachomatis | 1 | 2003 | 239 | 0.050 |
Why?
|
| Cell Differentiation | 4 | 2011 | 11651 | 0.050 |
Why?
|
| Carcinoma | 1 | 2013 | 2324 | 0.050 |
Why?
|
| Aplysia | 2 | 2012 | 40 | 0.050 |
Why?
|
| Genome, Viral | 1 | 2005 | 674 | 0.050 |
Why?
|
| Body Patterning | 1 | 2005 | 634 | 0.050 |
Why?
|
| Access to Information | 2 | 2016 | 317 | 0.040 |
Why?
|
| Embryonic Development | 1 | 2005 | 722 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2008 | 2926 | 0.040 |
Why?
|
| Pharmaceutical Preparations | 1 | 2008 | 1086 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2007 | 1343 | 0.040 |
Why?
|
| Protein Transport | 1 | 2006 | 1942 | 0.040 |
Why?
|
| Telomerase | 2 | 2016 | 750 | 0.040 |
Why?
|
| Lung Neoplasms | 3 | 2015 | 13485 | 0.040 |
Why?
|
| Repressor Proteins | 3 | 2011 | 2978 | 0.040 |
Why?
|
| Microsatellite Instability | 2 | 2014 | 726 | 0.040 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 2 | 2011 | 80 | 0.040 |
Why?
|
| Cloning, Molecular | 4 | 2007 | 4168 | 0.040 |
Why?
|
| Chromosome Mapping | 2 | 2005 | 4619 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2008 | 3158 | 0.040 |
Why?
|
| Phosphoproteins | 1 | 2008 | 2448 | 0.040 |
Why?
|
| Virus Replication | 1 | 2007 | 2457 | 0.040 |
Why?
|
| Sarcoma | 1 | 2010 | 1802 | 0.040 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 2 | 2013 | 904 | 0.040 |
Why?
|
| Ligands | 1 | 2006 | 3275 | 0.040 |
Why?
|
| Deuterium | 1 | 2018 | 105 | 0.040 |
Why?
|
| Brain | 3 | 2018 | 27159 | 0.040 |
Why?
|
| Comparative Genomic Hybridization | 2 | 2010 | 474 | 0.040 |
Why?
|
| Point Mutation | 1 | 2004 | 1591 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 4 | 2010 | 6066 | 0.040 |
Why?
|
| Rats | 4 | 2007 | 23717 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2004 | 1080 | 0.040 |
Why?
|
| Data Mining | 2 | 2014 | 560 | 0.040 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2007 | 1163 | 0.040 |
Why?
|
| Mice, Transgenic | 4 | 2014 | 9547 | 0.040 |
Why?
|
| Bipolar Disorder | 1 | 2015 | 5130 | 0.040 |
Why?
|
| Kinetics | 1 | 2006 | 6287 | 0.040 |
Why?
|
| Transplantation, Heterologous | 3 | 2012 | 2391 | 0.040 |
Why?
|
| Depressive Disorder | 1 | 2011 | 3715 | 0.040 |
Why?
|
| Positron-Emission Tomography | 2 | 2011 | 6550 | 0.040 |
Why?
|
| Natural Language Processing | 2 | 2004 | 1203 | 0.040 |
Why?
|
| Colonic Neoplasms | 1 | 2009 | 2534 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2004 | 2885 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2018 | 580 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2011 | 3967 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2018 | 447 | 0.030 |
Why?
|
| Signal Processing, Computer-Assisted | 2 | 2015 | 1457 | 0.030 |
Why?
|
| Eukaryotic Initiation Factor-1 | 1 | 2016 | 31 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2018 | 6214 | 0.030 |
Why?
|
| Aged, 80 and over | 7 | 2018 | 59550 | 0.030 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5387 | 0.030 |
Why?
|
| DNA | 1 | 2010 | 7208 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2015 | 1762 | 0.030 |
Why?
|
| Proportional Hazards Models | 3 | 2016 | 12534 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2013 | 13050 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 2 | 2017 | 5444 | 0.030 |
Why?
|
| RNA, Viral | 1 | 2004 | 2867 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2015 | 130 | 0.030 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2007 | 1642 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2008 | 4410 | 0.030 |
Why?
|
| Neurons | 2 | 2012 | 9515 | 0.030 |
Why?
|
| Directed Molecular Evolution | 1 | 2016 | 167 | 0.030 |
Why?
|
| Amino Acid Substitution | 2 | 2014 | 1742 | 0.030 |
Why?
|
| Disease Progression | 4 | 2018 | 13640 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 2 | 2010 | 1604 | 0.030 |
Why?
|
| Skin | 1 | 2008 | 4499 | 0.030 |
Why?
|
| Medical Oncology | 1 | 2007 | 2340 | 0.030 |
Why?
|
| Receptors, Androgen | 2 | 2012 | 1089 | 0.030 |
Why?
|
| Tuberous Sclerosis | 1 | 2003 | 1039 | 0.030 |
Why?
|
| Organ Specificity | 2 | 2013 | 1966 | 0.030 |
Why?
|
| Genotype | 4 | 2014 | 13036 | 0.030 |
Why?
|
| Chromatin | 2 | 2017 | 2977 | 0.030 |
Why?
|
| Replication Origin | 1 | 2014 | 77 | 0.030 |
Why?
|
| Endometrial Neoplasms | 2 | 2014 | 1380 | 0.030 |
Why?
|
| DNA Polymerase III | 1 | 2014 | 52 | 0.030 |
Why?
|
| Clostridium | 1 | 2014 | 100 | 0.030 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2004 | 1836 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2014 | 76 | 0.030 |
Why?
|
| Hydrodynamics | 1 | 2015 | 163 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2010 | 3073 | 0.030 |
Why?
|
| Class Ia Phosphatidylinositol 3-Kinase | 1 | 2014 | 76 | 0.030 |
Why?
|
| Up-Regulation | 2 | 2016 | 4142 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2015 | 350 | 0.030 |
Why?
|
| Molecular Conformation | 1 | 2015 | 540 | 0.030 |
Why?
|
| Germany | 2 | 2009 | 882 | 0.030 |
Why?
|
| Wnt Proteins | 1 | 2018 | 722 | 0.030 |
Why?
|
| Research Design | 2 | 2007 | 6207 | 0.030 |
Why?
|
| Succinate Dehydrogenase | 1 | 2014 | 148 | 0.030 |
Why?
|
| E2F3 Transcription Factor | 1 | 2013 | 36 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2013 | 56 | 0.030 |
Why?
|
| Liver | 3 | 2017 | 7571 | 0.030 |
Why?
|
| Zebrafish | 1 | 2005 | 3035 | 0.030 |
Why?
|
| Organisms, Genetically Modified | 1 | 2013 | 63 | 0.030 |
Why?
|
| Medical Records | 2 | 2013 | 1408 | 0.030 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2015 | 300 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2016 | 326 | 0.030 |
Why?
|
| BRCA2 Protein | 1 | 2018 | 802 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 2 | 2016 | 2823 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2011 | 6104 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 2678 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2015 | 640 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2011 | 5022 | 0.030 |
Why?
|
| Taxoids | 1 | 2016 | 665 | 0.030 |
Why?
|
| Genes, erbB-2 | 1 | 2013 | 161 | 0.030 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 1 | 2012 | 34 | 0.030 |
Why?
|
| Hydroxyprostaglandin Dehydrogenases | 1 | 2012 | 31 | 0.030 |
Why?
|
| GATA3 Transcription Factor | 1 | 2013 | 163 | 0.030 |
Why?
|
| Ribosomes | 1 | 2016 | 496 | 0.030 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2016 | 572 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2016 | 2012 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 2 | 2011 | 3609 | 0.030 |
Why?
|
| Cell Physiological Phenomena | 1 | 2013 | 149 | 0.020 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2012 | 74 | 0.020 |
Why?
|
| Cytochrome P-450 CYP3A | 1 | 2012 | 117 | 0.020 |
Why?
|
| Symbiosis | 1 | 2014 | 297 | 0.020 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2013 | 182 | 0.020 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2016 | 4652 | 0.020 |
Why?
|
| Gene Frequency | 2 | 2013 | 3624 | 0.020 |
Why?
|
| RNA Splicing | 1 | 2016 | 903 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2015 | 4522 | 0.020 |
Why?
|
| Transcription, Genetic | 3 | 2010 | 7609 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2013 | 545 | 0.020 |
Why?
|
| Obesity | 1 | 2013 | 13090 | 0.020 |
Why?
|
| New York City | 1 | 2013 | 736 | 0.020 |
Why?
|
| COS Cells | 1 | 2013 | 1135 | 0.020 |
Why?
|
| Neurofibromin 2 | 1 | 2012 | 269 | 0.020 |
Why?
|
| Histone Deacetylase 1 | 1 | 2011 | 133 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 2014 | 735 | 0.020 |
Why?
|
| Genes | 1 | 2015 | 1824 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2014 | 705 | 0.020 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2013 | 382 | 0.020 |
Why?
|
| Survival Rate | 2 | 2016 | 12825 | 0.020 |
Why?
|
| DNA-Binding Proteins | 3 | 2017 | 9611 | 0.020 |
Why?
|
| Cadherins | 1 | 2015 | 902 | 0.020 |
Why?
|
| Metagenome | 1 | 2014 | 464 | 0.020 |
Why?
|
| E2F Transcription Factors | 1 | 2011 | 270 | 0.020 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2016 | 1105 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2011 | 287 | 0.020 |
Why?
|
| Computers | 1 | 2013 | 589 | 0.020 |
Why?
|
| Intellectual Property | 1 | 2010 | 32 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2013 | 8307 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2012 | 465 | 0.020 |
Why?
|
| Phylogeny | 2 | 2008 | 2840 | 0.020 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2011 | 211 | 0.020 |
Why?
|
| Cytokinesis | 1 | 2011 | 170 | 0.020 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2012 | 409 | 0.020 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2012 | 638 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 381 | 0.020 |
Why?
|
| Bacterial Proteins | 1 | 2003 | 3833 | 0.020 |
Why?
|
| Half-Life | 1 | 2010 | 648 | 0.020 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2012 | 616 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2010 | 317 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2013 | 1337 | 0.020 |
Why?
|
| Viral Proteins | 2 | 2008 | 1801 | 0.020 |
Why?
|
| Genomic Instability | 1 | 2013 | 716 | 0.020 |
Why?
|
| RNA-Induced Silencing Complex | 1 | 2009 | 52 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2014 | 1615 | 0.020 |
Why?
|
| Cells, Cultured | 3 | 2013 | 18984 | 0.020 |
Why?
|
| Glucose | 2 | 2011 | 4340 | 0.020 |
Why?
|
| Genes, cdc | 1 | 2009 | 113 | 0.020 |
Why?
|
| Biochemistry | 1 | 2010 | 115 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 874 | 0.020 |
Why?
|
| Heterozygote | 1 | 2015 | 2795 | 0.020 |
Why?
|
| Biological Evolution | 1 | 2014 | 1075 | 0.020 |
Why?
|
| Adipogenesis | 1 | 2011 | 370 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2010 | 472 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2011 | 747 | 0.020 |
Why?
|
| Skin Abnormalities | 1 | 2008 | 60 | 0.020 |
Why?
|
| Lymphatic Metastasis | 2 | 2009 | 2901 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2011 | 1697 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2009 | 369 | 0.020 |
Why?
|
| Sequence Deletion | 1 | 2012 | 1494 | 0.020 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2008 | 153 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 3 | 2014 | 22352 | 0.020 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2008 | 102 | 0.020 |
Why?
|
| Feces | 1 | 2014 | 1505 | 0.020 |
Why?
|
| Pyrroles | 1 | 2014 | 1121 | 0.020 |
Why?
|
| MAP Kinase Signaling System | 1 | 2014 | 1491 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2014 | 1405 | 0.020 |
Why?
|
| Whole-Body Irradiation | 1 | 2008 | 438 | 0.020 |
Why?
|
| Models, Animal | 1 | 2013 | 2121 | 0.020 |
Why?
|
| Cholesterol | 1 | 2016 | 2903 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2018 | 5503 | 0.020 |
Why?
|
| ZAP-70 Protein-Tyrosine Kinase | 1 | 2007 | 69 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2008 | 915 | 0.020 |
Why?
|
| Cell Movement | 2 | 2010 | 5199 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2013 | 1197 | 0.020 |
Why?
|
| Cell Survival | 2 | 2008 | 5748 | 0.020 |
Why?
|
| Ribonuclease III | 1 | 2008 | 271 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2009 | 462 | 0.020 |
Why?
|
| Astrocytoma | 1 | 2011 | 773 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2011 | 960 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 615 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2012 | 1110 | 0.020 |
Why?
|
| Colitis | 1 | 2014 | 1238 | 0.020 |
Why?
|
| Molecular Biology | 1 | 2009 | 573 | 0.020 |
Why?
|
| Education | 1 | 2008 | 531 | 0.020 |
Why?
|
| Indoles | 1 | 2014 | 1834 | 0.020 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2007 | 228 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides, Antisense | 1 | 2005 | 57 | 0.020 |
Why?
|
| Spermatogenesis | 1 | 2006 | 259 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 3587 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2009 | 1007 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2015 | 4032 | 0.010 |
Why?
|
| STAT3 Transcription Factor | 1 | 2009 | 872 | 0.010 |
Why?
|
| Serotonin | 1 | 2009 | 1045 | 0.010 |
Why?
|
| Untranslated Regions | 1 | 2004 | 30 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2009 | 2628 | 0.010 |
Why?
|
| Immune System | 1 | 2010 | 800 | 0.010 |
Why?
|
| Genetic Loci | 1 | 2013 | 2630 | 0.010 |
Why?
|
| Ecdysone | 1 | 2003 | 19 | 0.010 |
Why?
|
| Callithrix | 1 | 2004 | 95 | 0.010 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2004 | 114 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2002 | 9404 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2018 | 41710 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 2007 | 853 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2005 | 1550 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 2846 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2009 | 3616 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2008 | 1040 | 0.010 |
Why?
|
| Breast | 1 | 2012 | 1971 | 0.010 |
Why?
|
| Mice, Knockout | 2 | 2008 | 14471 | 0.010 |
Why?
|
| Alleles | 1 | 2014 | 6895 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2010 | 1895 | 0.010 |
Why?
|
| Genes, Insect | 1 | 2003 | 265 | 0.010 |
Why?
|
| DNA, Viral | 1 | 2009 | 2201 | 0.010 |
Why?
|
| RNA, Double-Stranded | 1 | 2004 | 292 | 0.010 |
Why?
|
| Genes, Essential | 1 | 2004 | 185 | 0.010 |
Why?
|
| Genes, Homeobox | 1 | 2003 | 289 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2014 | 39309 | 0.010 |
Why?
|
| Overweight | 1 | 2013 | 2446 | 0.010 |
Why?
|
| HEK293 Cells | 1 | 2011 | 4276 | 0.010 |
Why?
|
| Central Nervous System | 1 | 2009 | 1345 | 0.010 |
Why?
|
| Time Factors | 3 | 2009 | 40149 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 928 | 0.010 |
Why?
|
| Child, Preschool | 3 | 2015 | 42577 | 0.010 |
Why?
|
| Introns | 1 | 2004 | 966 | 0.010 |
Why?
|
| Europe | 1 | 2008 | 3430 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 2005 | 910 | 0.010 |
Why?
|
| Kidney | 1 | 2017 | 7074 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2013 | 9661 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2009 | 2764 | 0.010 |
Why?
|
| Imidazoles | 1 | 2007 | 1168 | 0.010 |
Why?
|
| Virus Latency | 1 | 2004 | 359 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 1989 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2017 | 4353 | 0.010 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2004 | 481 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2010 | 6329 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2007 | 2510 | 0.010 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2011 | 1481 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2006 | 2677 | 0.010 |
Why?
|
| Nervous System | 1 | 2003 | 542 | 0.010 |
Why?
|
| Adipocytes | 1 | 2007 | 1196 | 0.010 |
Why?
|
| Nevus | 1 | 2002 | 204 | 0.010 |
Why?
|
| Depressive Disorder, Major | 1 | 2018 | 4810 | 0.010 |
Why?
|
| Retinitis Pigmentosa | 1 | 2004 | 395 | 0.010 |
Why?
|
| Reference Standards | 1 | 2004 | 1010 | 0.010 |
Why?
|
| Neuropeptides | 1 | 2005 | 950 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 1244 | 0.010 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2004 | 1117 | 0.010 |
Why?
|
| Logistic Models | 1 | 2013 | 13278 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2009 | 3721 | 0.010 |
Why?
|
| Young Adult | 2 | 2016 | 59939 | 0.010 |
Why?
|
| Research | 1 | 2007 | 1977 | 0.010 |
Why?
|
| Internationality | 1 | 2004 | 1006 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2007 | 2572 | 0.010 |
Why?
|
| Smoking | 1 | 2015 | 9077 | 0.010 |
Why?
|
| Sensitivity and Specificity | 2 | 2003 | 14652 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2011 | 3359 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2008 | 2631 | 0.010 |
Why?
|
| Age Factors | 1 | 2014 | 18397 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 10745 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 2004 | 1394 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 8045 | 0.010 |
Why?
|
| Piperazines | 1 | 2007 | 2547 | 0.010 |
Why?
|
| Adolescent | 3 | 2015 | 88904 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 8717 | 0.010 |
Why?
|
| Child | 3 | 2015 | 80668 | 0.010 |
Why?
|
| Peptides | 1 | 2008 | 4344 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2003 | 1540 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2005 | 1704 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 7475 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2011 | 6596 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2009 | 2884 | 0.010 |
Why?
|
| Multifactorial Inheritance | 1 | 2004 | 1425 | 0.010 |
Why?
|
| Hematologic Neoplasms | 1 | 2007 | 1926 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2007 | 3314 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2013 | 22248 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2007 | 3408 | 0.010 |
Why?
|
| Risk Factors | 2 | 2013 | 74881 | 0.010 |
Why?
|
| Cystic Fibrosis | 1 | 2004 | 1285 | 0.010 |
Why?
|
| United States | 2 | 2015 | 72951 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2008 | 6422 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 18330 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2002 | 8540 | 0.010 |
Why?
|
| Retrospective Studies | 2 | 2013 | 81635 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 12985 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 15416 | 0.000 |
Why?
|
| Severity of Illness Index | 1 | 2002 | 15908 | 0.000 |
Why?
|